Skip to content
Main menu
  • about
    • Who we are
    • Hydrix Group
    • Board & Executive
    • Careers
    • Corporate Governance
  • markets
    • Cardiac & MedTech
    • Regulatory & Clinical Affairs | Medical Device Regulation
    • Industrial & Defence | Technology Development
  • services
  • our work
  • news & articles
  • investors
  • contact

Investor Information

Hydrix is a powerful product innovation company. 
We aspire to positively impact the health, safety, and wellbeing of 1 Billion lives.

Hydrix Services

Hydrix Group’s innovation engine delivers world class design, engineering and regulatory services

Hydrix Medical

Diagnostic, monitoring & interventional MedTech products which improve patient quality of life

Hydrix Ventures

Pick winning investments
in high potential client medical technologies

Recent Investor Updates

26 OCTOBER 2021
Hydrix Appoints Mr Paul Lewis MBE FAICD to the Board

26 OCTOBER 2021
Letter to Shareholders - Annual General Meeting

26 OCTOBER 2021
Notice of Annual General Meeting/Proxy Form

26 OCTOBER 2021
Appendix 4G and Corporate Governance Statement

26 OCTOBER 2021
2021 Annual Report to shareholders

14 SEPTEMBER 2021
ASX Announcement - Hydrix On Track for Cardiac Product Sales in H1 CY22

31 AUGUST 2021
Letter from Executive Chairman

31 AUGUST 2021
Appendix 4E and Financial Report

31 AUGUST 2021
Proposed issue of securities

31 AUGUST 2021
Commercial arrangement between Hydrix and Memphasys

2 AUGUST 2021
ASX Announcement -  US Implant AngelMed Guardian

 

 

To view past announcements visit the Hydrix page on the ASX

Hydrix Annual Report 2021

Please click the image above to access our 2021 Annual Report

Investor Relations

For all shareholder enquiries, please contact us via the form below:

Are you a current shareholder?

To view the latest Hydrix share price and announcements, visit the Hydrix page on the ASX

Hydrix in the Media

Hydrix Executive Chairman, Gavin Coote, presents to the Bell Potter Network

Hydrix Executive Chairman, Gavin Coote speaks to Proactive's Andrew Scott regarding the AngelMed FDA approval

Hydrix Executive Chairman, Gavin Coote, hosted an investor conference call to discuss financial results

The Market Unpacked interviews Gavin Coote, Hydrix  Executive Chairman

Journalist Tim Boreham discovers a quiet achiever propelling the MedTech industry

Visit our
YouTube page
to view other
Hydrix related media

Ready to explore how we can help?

Let's talk

 

Tell us which area(s) you're interested in

Hydrix

Address: 30-32 Compark Circuit Mulgrave, Vic, 3170

Phone: +61 3 9550 8100

Follow us on LinkedIn :

Back to top

COMPANY

Who We Are
Board & Executive
Careers
Corporate Governance
News & Articles
Investors

MARKETS

Cardiac & MedTech
Regulatory & Clinical
Industrial & Defence

Ready to take the next steps in your project? Learn how Hydrix can help

© 2021 Hydrix Ltd  |  Privacy Policy